Jonathon Willatt

MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies

The incidence of hepatocellular carcinoma (HCC) is expected to increase in the next 2 decades, largely due to hepatitis C infection and secondary cirrhosis. HCC is being detected at an earlier stage owing to the implementation of screening programs. Biopsy is no longer required prior to treatment, and diagnosis of HCC is heavily dependent on imaging characteristics. The most recent recommendations by the American Association for the Study of Liver Diseases (AASLD) state that a diagnosis of HCC can be made if a mass larger than 2 cm shows typical features of HCC (hypervascularity in the arterial phase and washout in the venous phase) at contrast material-enhanced computed tomography or magnetic resonance (MR) imaging or if a mass measuring 1-2 cm shows these features at both modalities. There is an ever-increasing demand on radiologists to detect smaller tumors, when curative therapies are most effective. However, the major difficulty in imaging cirrhosis is the characterization of hypervascular nodules smaller than 2 cm, which often have nonspecific imaging characteristics. The authors present a review of the MR imaging and pathologic features of regenerative nodules and dysplastic nodules and focus on HCC in the cirrhotic liver, with particular reference to small tumors and lesions that may mimic HCC. The authors also review the sensitivity of MR imaging for the detection of these tumors and discuss the staging of HCC and the treatment options in the context of the guidelines of the AASLD and the imaging criteria required by the United Network for Organ Sharing for transplantation. MR findings following ablation and chemoembolization are also reviewed.

Vascular Malformation and Hemangiomatosis Syndromes: Spectrum of Imaging Manifestations

OBJECTIVE The purpose of this review is to describe the role of imaging and associated findings in the diagnosis of blue rubber bleb nevus syndrome, Proteus syndrome, Klippel-Trénaunay syndrome, and Kasabach-Merritt syndrome. CONCLUSION Blue rubber bleb nevus, Proteus, Klippel-Trénaunay, and Kasabach-Merritt syndromes are a diverse group of vascular malformation and hemangiomatosis syndromes. Both cutaneous and visceral vascular lesions are associated with these disorders. Accurate diagnosis of these syndromes is important because they can be associated with serious complications, including life-threatening hemorrhage.

MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation

OBJECTIVE The objective of our study was to evaluate the evolution of the appearances of successfully ablated renal masses on CT and MRI. MATERIALS AND METHODS We conducted a retrospective review of 28 solid renal masses in 25 patients who underwent percutaneous radiofrequency ablation (RFA) between July 2003 and July 2006 in whom there was no evidence of residual tumor during at least 1 year of imaging follow-up and there was postablation biopsy proof of nonviable tissue within the ablation cavity. Three radiologists assessed the size, morphology, and CT or MRI characteristics of the initial tumor and of the ablated tumor or ablation cavity at imaging follow-up 1-2, 3-5, 6-11, and 12-24 months after RFA. RESULTS The mean initial tumor volume was 5.5 cm(3) (range, 0.3-22.3 cm(3)). Within 1-2 months, the postablation beds of small masses (< or = 3 cm(3)) were larger than the volume of the initial tumor. Large masses (> 3 cm(3)) did not show this increase in volume. At 12 months after RFA, the postablation beds had decreased in size but had not disappeared. On CT, the postablation beds did not show enhancement at any time. On MRI, the postablation beds often showed a thin rim of peripheral enhancement. Imaging follow-up often revealed local stranding in the perinephric fat adjacent to the ablation site. Exophytic tumors were more likely to separate from the renal parenchyma as they contracted toward their epicenter and were more likely to reveal a complete halo of soft-tissue attenuation in the adjacent perinephric fat, which became more apparent on the longer-term follow-up imaging studies. CONCLUSION Successfully ablated tumors show predictable imaging features that can be used to guide interpretation of CT and MRI surveillance examinations.

Primary hepatic lymphoma: imaging findings.

Primary hepatic lymphoma (PHL) is rare, accounting for less than 1% of all extranodal lymphomas. In this article, we retrospectively reviewed the imaging features of 12 pathologically proven cases of primary hepatic lymphoma.

Interventional therapies for hepatocellular carcinoma.

Abstract Hepatocellular carcinoma is the third most common cause of cancer-related death. In the past few years, staging systems have been developed that enable patients to be stratified into treatment algorithms in a multidisciplinary setting. Several of these treatments involve minimally invasive image-guided therapy that can be performed by radiologists.

CT appearances following laparoscopic partial nephrectomy for renal cell carcinoma using a rolled cellulose bolster

Abstract Abstract Purpose: To describe the evolving computed tomography (CT) appearances of a cellulose surgical bolster used as a hemostatic agent in patients who undergo laparoscopic partial nephrectomy for renal cell carcinoma. Materials and methods: We retrospectively reviewed the follow-up CT studies of 33 patients with stage T1N0M0 renal carcinoma who underwent laparoscopic partial nephrectomy using a rolled, oxidized, regenerated cellulose sheet sutured in place as a bolster in the parenchymal defect. Thirteen patients undergoing laparoscopic partial nephrectomy without the use of a bolster were also evaluated to differentiate imaging features. Results: The bolster-related masses were significantly larger than those seen in the non-bolster patients. There was a decrease in size of the post-operative bolster-related mass with time. The bolster shape evolved with time, initially appearing oval, and becoming irregular with decreasing size. Equivocal increase in attenuation of 10–20 HU was seen in 6 patients. Increase in attenuation of greater than 20 HU was seen in 3 patients. There was no evidence of tumor recurrence in any of the patients. Invagination of fat was seen in two bolster-related masses at 18 months or greater. Conclusions: Cellulose bolster has a variable appearance on follow-up CT exams. Evolutionary features include reduction in bolster size and shape with time leading finally to non-visualization. Bolster enhancement can mimic abscesses and tumor recurrence.

Ablation techniques for primary and metastatic liver tumors

Ablative treatment methods have emerged as safe and effective therapies for patients with primary and secondary liver tumors who are not surgical candidates at the time of diagnosis. This article reviews the current literature and describes the techniques, complications and results for radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation.

Imaging of Renal Transplant: Utility and Spectrum of Diagnostic Findings

Several noninvasive imaging techniques have been developed and improved over recent years that facilitate detection of both vascular and nonvascular postoperative complications as well as diagnosis of diseases related to the transplanted organ itself. In this article, we present a multi-modality review of the spectrum of pathology related to renal transplantation.

Imaging and management of the incidentally discovered renal mass

Abstract Improvements in imaging technology and the expanding use of imaging have led to a rapid increase in the discovery of incidental renal lesions. These can present both the radiologist and the referring clinician with diagnostic dilemmas. This article addresses the most frequently encountered lesions and provides a framework for the diagnostic and management pathways for both solid and cystic lesions.

Computed tomography urography: Trends in positivity rates over time

Purpose: To investigate changes in usage of computed tomography urography (CTU), indications for CTU, and rates of positive findings over time. Methods: Retrospective review of data from April 2000 to December 2005 assessed rates of overall positive findings, rates of suspected transitional cell carcinomas (TCCs), benign genitourinary (GU), and significant non-GU findings. Data were analyzed based on specialty of ordering physicians and on requisition indications. Results: One thousand two hundred seventy-one patients had 1746 CTUs, including 952 men (1259 studies) and 319 women (487 studies) with mean age of 61 years. Computed tomography urographies increased from 265 in 2001 to 443 in 2004. Eighty-nine percent were ordered by urologists, 4% by oncologists, 1% by emergency physicians, and 6% by other specialties. Sixty-two percent of first-time studies were ordered for possible GU malignancy, 24% for hematuria, and 14% for other reasons. Eight hundred sixty-one examinations (49%) showed significant findings. The rate of all positive examinations, analyzed in 6-month periods, varied from 37% to 54%, but no time trend was identified. First-time patient examinations had positive examinations in 46% to 62% of cases. Similarly, no trends were found for examinations interpreted as possible TCC (17%-32%), renal stones (9%-18%), renal masses (1%-6%), causes of hematuria (15%-26%), and acute non-GU findings (2%-9%). The rate of positive findings by ordering specialty varied minimally from 49% to 53%. No change occurred in the proportions of indications for CTU over time. Conclusions: In 5 years, the number of CTU examinations per year increased 1.5-fold. The rate of CTU findings positive for suspected TCC, stones, and other causes of hematuria showed no decline or increase. If precautions are taken regarding proper indications for CTU, the overall rates of positive findings may not substantially change over time, thereby only submitting high-risk patients to this examination.